PFS in R/R Mantle Cell Lymphoma is Improved by Ibrutinib-Venetoclax.

Published Date: 18 Dec 2023

Should the accelerated approval be withdrawn, will the results bring ibrutinib's role in MCL back?

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

2.

High numbers of rural patients cross state lines for cancer care

3.

Watch for Psoriasis After Cancer Immunotherapy, Study Says

4.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

5.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot